000 01701 a2200457 4500
005 20250517075623.0
264 0 _c20170209
008 201702s 0 0 eng d
022 _a1423-0380
024 7 _a10.1007/s13277-016-4868-6
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aZhijun, Huang
245 0 0 _aPre-clinical characterization of 4SC-202, a novel class I HDAC inhibitor, against colorectal cancer cells.
_h[electronic resource]
260 _bTumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
_cAug 2016
300 _a10257-67 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAnimals
650 0 4 _aAntineoplastic Agents
_xpharmacology
650 0 4 _aApoptosis
_xdrug effects
650 0 4 _aBenzamides
_xpharmacology
650 0 4 _aBlotting, Western
650 0 4 _aCell Line, Tumor
650 0 4 _aCell Proliferation
_xdrug effects
650 0 4 _aColorectal Neoplasms
_xpathology
650 0 4 _aEnzyme-Linked Immunosorbent Assay
650 0 4 _aFlow Cytometry
650 0 4 _aGene Knockdown Techniques
650 0 4 _aHistone Deacetylase Inhibitors
_xpharmacology
650 0 4 _aHumans
650 0 4 _aMice
650 0 4 _aMice, Inbred C57BL
650 0 4 _aMice, Nude
650 0 4 _aXenograft Model Antitumor Assays
700 1 _aShusheng, Wang
700 1 _aHan, Min
700 1 _aJianping, Li
700 1 _aLi-Sen, Qin
700 1 _aDechun, Li
773 0 _tTumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
_gvol. 37
_gno. 8
_gp. 10257-67
856 4 0 _uhttps://doi.org/10.1007/s13277-016-4868-6
_zAvailable from publisher's website
999 _c25689474
_d25689474